Prescription medication · Third-Generation Cephalosporin
ceftriaxone
Also sold as Rocephin. Ceftriaxone treats infections like pneumonia, ear infections, skin infections, and urinary tract infections.
Data updated 2026-05-15
- 31,340
- FDA reportsModerately reported
- 1
- Recall record
What the data shows
ceftriaxone (Rocephin) is a prescription Third-Generation Cephalosporin, reported at a middle-of-the-pack volume (31,340 FDA reports).
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
ceftriaxone (Rocephin) is a prescription Third-Generation Cephalosporin. Ceftriaxone treats infections like pneumonia, ear infections, skin infections, and urinary tract infections.
Ceftriaxone is an antibiotic medicine. It fights bacteria in your body to treat different kinds of infections.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$1.50/unit
Generic Available
Yes (11 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
NADAC price trail: CEFTRIAXONE 1 GM VIAL
Same CMS presentation as the headline generic unit price above (3 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +3.4% vs prior release.
| Effective | NADAC / unit | vs prior | NDCs |
|---|---|---|---|
| July 17, 2024 | $1.52/EA | - | 1 |
| October 23, 2024 | $1.50/EA | -0.9% | 1 |
| December 18, 2024 | $1.55/EA | +3.4% | 11 |
What it does
Ceftriaxone treats infections like pneumonia, ear infections, skin infections, and urinary tract infections.
Common side effects
Pain, hardness, or tenderness where you got the shot, Rash, Increased eosinophils (a type of white blood cell)
Key warnings
Do not use ceftriaxone if you are allergic to it or other cephalosporin antibiotics.
The sections below are summarized in plain English from ceftriaxone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Ceftriaxone belongs to a class of drugs called cephalosporins. It works by stopping the growth of bacteria. This helps your body fight off the infection.
Side Effects (from patient reports)
Based on 31,340 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for ceftriaxone, by number of reports
- Pyrexia
Pyrexia
1,677 reports
- Acute Kidney Injury
Acute Kidney Injury
1,533 reports
- Condition Aggravated
Condition Aggravated
1,274 reports
- Dyspnoea
Dyspnoea
1,069 reports
- Pneumonia
Pneumonia
1,035 reports
- Drug Interaction
Drug Interaction
1,022 reports
- Vomiting
Vomiting
970 reports
- Nausea
Nausea
922 reports
- Drug Reaction With Eosinophilia And Systemic Symptoms
Drug Reaction With Eosinophilia And Systemic Symptoms
892 reports
- Diarrhoea
Diarrhoea
865 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for ceftriaxone each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where ceftriaxone sits
ceftriaxone has more FDA adverse-event reports than 65% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is ceftriaxone; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 31,340 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.
Total Reports
31,340
Reports Mentioning Death
5,390
17.2% of reports — not proof of cause
Hospitalization Reports
17,015
Top Indication
Product Used For Unknown Indication
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 3 | PYREXIA | 1,677 |
| 4 | ACUTE KIDNEY INJURY | 1,533 |
| 5 | CONDITION AGGRAVATED | 1,274 |
| 6 | DYSPNOEA | 1,069 |
| 7 | PNEUMONIA | 1,035 |
| 8 | DRUG INTERACTION | 1,022 |
| 9 | VOMITING | 970 |
| 10 | NAUSEA | 922 |
| 11 | DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 892 |
| 12 | DIARRHOEA | 865 |
| 13 | HYPOTENSION | 850 |
| 14 | RASH | 826 |
| 15 | SEPSIS | 822 |
| 17 | RESPIRATORY FAILURE | 735 |
| 18 | THROMBOCYTOPENIA | 700 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
Do not use ceftriaxone if you are allergic to it or other cephalosporin antibiotics. Newborns should not receive ceftriaxone if they are premature or have too much bilirubin in their blood. Ceftriaxone should not be mixed with IV solutions containing calcium, especially in newborns, due to the risk of serious complications.
Common Questions
What if I'm allergic to penicillin?
Can ceftriaxone be given with calcium?
How long will I need to take ceftriaxone?
What should I avoid while taking ceftriaxone?
Can ceftriaxone cause diarrhea?
What if I have kidney problems?
Can ceftriaxone treat a viral infection?
What if my symptoms don't improve?
Is it safe to drive while taking ceftriaxone?
Can I get a fungal infection while taking this medicine?
What are the common side effects of ceftriaxone?
What drug class is ceftriaxone?
What pregnancy or breastfeeding source fields are listed for ceftriaxone?
Has ceftriaxone been recalled?
Active Recalls
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Franck's Lab Inc dba Trinity Care Solutions
Related Medications in Third-Generation Cephalosporin
Other drugs grouped near ceftriaxone - same-class peers and common alternatives.
amikacin
Amikin
Amikacin is an antibiotic medicine.
Compare with ceftriaxone →
amoxicillin
Amoxil
Amoxicillin and Clavulanate Potassium is a combination medicine used to fight bacterial infections.
Compare with ceftriaxone →
amoxicillin/clavulanate
Augmentin
Augmentin is a combination of two medicines, amoxicillin and clavulanate.
Compare with ceftriaxone →
ampicillin/sulbactam
Unasyn
Unasyn is a combination of two antibiotics that fights bacteria in your body.
Compare with ceftriaxone →
azithromycin
Zithromax, Z-Pack
Azithromycin is an antibiotic that fights bacteria.
Compare with ceftriaxone →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for ceftriaxone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 31,340.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 17.20%.
- amiodarone Δ 0.08 pts · 10,687 reports · Class III Antiarrhythmic 17.28%death share
- valganciclovir Δ 0.15 pts · 18,056 reports · Antiviral (Nucleoside Analog) 17.35%death share
- dapagliflozin Δ 0.17 pts · 50,521 reports · SGLT2 Inhibitor 17.03%death share
- desipramine Δ 0.18 pts · 1,275 reports · Tricyclic Antidepressant (TCA) 17.02%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ceftriaxone
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ceftriaxone
The FDA label for ceftriaxone (sold under brand names such as Rocephin) classifies it as a prescription-only medication in the Third-Generation Cephalosporin class. Ceftriaxone treats infections like pneumonia, ear infections, skin infections, and urinary tract infections. Official labeling lists 7 commonly reported side effects, including Pain, hardness, or tenderness where you got the shot, Rash, Increased eosinophils (a type of white blood cell).
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 31,340 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS shows a generic unit cost of $1.50.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 1 recall record on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: January 19, 2026
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages